Studies using prostate cancer cells have shown that miR-21 targets myristoylated alanine rich protein kinase c substrate (MARCKS), which is involved in cellular processes, such as cell adhesion and cell motility through regulation of the actin cytoskeleton. The gene discussed is MARCKS; the disease is prostate carcinoma.